What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cytokine
Thomas W.H. Kay spends much of his time researching Immunology, Internal medicine, Type 1 diabetes, Endocrinology and Insulitis.
He interconnects Nod and Proinsulin in the investigation of issues within Immunology.
His Type 1 diabetes research is multidisciplinary, incorporating elements of Pancreas transplantation and Islet, Insulin, Glycemic.
His Islet research incorporates elements of Apoptosis and Transplantation.
Thomas W.H. Kay has researched Endocrinology in several fields, including Downregulation and upregulation and Transcription factor.
His Insulitis study incorporates themes from CD8 and Major histocompatibility complex.
His most cited work include:
- Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. (1387 citations)
- SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine (693 citations)
- Improvement in outcomes of clinical islet transplantation: 1999-2010. (497 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Internal medicine, Endocrinology, Islet and NOD mice.
His Immunology study integrates concerns from other disciplines, such as Type 1 diabetes and Beta cell.
His Internal medicine course of study focuses on Diabetes mellitus and Pancreas and Autoantibody.
His work carried out in the field of Endocrinology brings together such families of science as Proinflammatory cytokine and Signal transduction.
The study incorporates disciplines such as Transplantation and Cell biology in addition to Islet.
His NOD mice research is multidisciplinary, relying on both T cell and Cytokine.
He most often published in these fields:
- Immunology (51.77%)
- Internal medicine (37.17%)
- Endocrinology (31.86%)
What were the highlights of his more recent work (between 2017-2021)?
- Islet (36.73%)
- Transplantation (27.43%)
- Cell biology (26.99%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Islet, Transplantation, Cell biology, NOD mice and Type 1 diabetes.
His research on Islet concerns the broader Internal medicine.
His work deals with themes such as Diabetes mellitus, Endocrinology and Gastroenterology, which intersect with Internal medicine.
The various areas that he examines in his NOD mice study include T cell and CD8.
His Type 1 diabetes research is multidisciplinary, incorporating perspectives in Proinsulin and Immunology, Immune system, Antigen.
Thomas W.H. Kay integrates Immunology with Sting in his study.
Between 2017 and 2021, his most popular works were:
- Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes (114 citations)
- Proinsulin C-peptide is an autoantigen in people with type 1 diabetes. (29 citations)
- Proinsulin C-peptide is an autoantigen in people with type 1 diabetes. (29 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cytokine
His scientific interests lie mostly in Type 1 diabetes, Transplantation, Islet, Diabetes mellitus and T cell.
His Type 1 diabetes research includes themes of C-peptide, Immunology, Antigen, Proinsulin and Autoimmunity.
The subject of his Islet research is within the realm of Insulin.
His Insulin research is under the purview of Internal medicine.
His Internal medicine research includes elements of Endocrinology and Bioenergetics.
As part of the same scientific family, Thomas W.H. Kay usually focuses on T cell, concentrating on NOD mice and intersecting with Cancer research, NFKB1 and NF-κB.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
